Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00829049Phase 4Terminated
A Phase 4 trial of tazarotene in acne vulgaris, sponsored by Allergan. Started Oct 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00829049.